All Updates

All Updates

icon
Filter
Partnerships
Telo Genomics and Emery Pharma put together their technologies to provide clinical R&D solutions
Precision Medicine
May 16, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Jun 20, 2024
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Jun 20, 2024
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Jun 20, 2024
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Jun 20, 2024
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Jun 20, 2024
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Jun 20, 2024
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Jun 20, 2024
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Jun 20, 2024
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Jun 20, 2024
Precision Medicine

Precision Medicine

May 16, 2024

Telo Genomics and Emery Pharma put together their technologies to provide clinical R&D solutions

Partnerships

  • Telo Genomics has partnered with contract research organization Emery Pharma to put together their respective technologies to provide clinical R&D solutions for its pharmaceutical and diagnostics sector clients.

  • Through this collaboration, both Telo Genomics and Emery Pharma aim to enhance their capability to offer cellular and molecular bioanalytical solutions. Telo Genomics brings its proprietary TeloView platform, capable of identifying genomic instability, into the partnership, while Emery Pharma provides services such as mass analysis, peptide mapping, glycan analysis, post-translational modifications, immunogenicity analysis, and general R&D and good laboratory practice (GLP) support.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.